Nervomatrix, an Israeli pain-relief neurostimulation device company, received a $3.5 million investment and plans to create its North American headquarters in Akron, Ohio, according to a MedCity News report.
The investment comes from an Akron-based investment firm, and the company has received 510(k) approval from the FDA to begin marketing its back-pain device. The device identifies pain points in the back by looking at electrical activity.
It also delivers electrical stimulation on the patient's skin close to the identified pain points.
Related Articles About Pain Management:
Study: Hippocampus Suppresses Pain During Stress
Comparison of Pain Symptoms Reveals Treatment Implications
Doctor Identifies "Text Neck" as New Medical Condition
It also delivers electrical stimulation on the patient's skin close to the identified pain points.
Related Articles About Pain Management:
Study: Hippocampus Suppresses Pain During Stress
Comparison of Pain Symptoms Reveals Treatment Implications
Doctor Identifies "Text Neck" as New Medical Condition